265 related articles for article (PubMed ID: 26590361)
1. Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals.
Isakova T; Cai X; Lee J; Katz R; Cauley JA; Fried LF; Hoofnagle AN; Satterfield S; Harris TB; Shlipak MG; Sarnak MJ; Ix JH;
J Bone Miner Res; 2016 Apr; 31(4):742-8. PubMed ID: 26590361
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study.
Jovanovich A; Bùzková P; Chonchol M; Robbins J; Fink HA; de Boer IH; Kestenbaum B; Katz R; Carbone L; Lee J; Laughlin GA; Mukamal KJ; Fried LF; Shlipak MG; Ix JH
J Clin Endocrinol Metab; 2013 Aug; 98(8):3323-31. PubMed ID: 23771921
[TBL] [Abstract][Full Text] [Related]
3. Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients.
Kanda E; Yoshida M; Sasaki S
BMC Nephrol; 2012 Sep; 13():122. PubMed ID: 23013306
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of Bone Turnover Identify Subsets of Chronic Kidney Disease Patients at Higher Risk for Fracture.
Hughes-Austin JM; Katz R; Semba RD; Kritchevsky SB; Bauer DC; Sarnak MJ; Ginsberg C; Shlipak MG; Lima F; Malluche HH; Ix JH
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2903-11. PubMed ID: 32474604
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
[TBL] [Abstract][Full Text] [Related]
7. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
[TBL] [Abstract][Full Text] [Related]
8. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.
Nakano C; Hamano T; Fujii N; Matsui I; Tomida K; Mikami S; Inoue K; Obi Y; Okada N; Tsubakihara Y; Isaka Y; Rakugi H
Clin J Am Soc Nephrol; 2012 May; 7(5):810-9. PubMed ID: 22362065
[TBL] [Abstract][Full Text] [Related]
9. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
[TBL] [Abstract][Full Text] [Related]
10. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
11. Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease.
Hall RK; Sloane R; Pieper C; Van Houtven C; LaFleur J; Adler R; Colón-Emeric C
J Am Geriatr Soc; 2018 Mar; 66(3):532-538. PubMed ID: 29319880
[TBL] [Abstract][Full Text] [Related]
12. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
[TBL] [Abstract][Full Text] [Related]
13. Association of Serum Klotho with Loss of Bone Mineral Density and Fracture Risk in Older Adults.
Chalhoub D; Marques E; Meirelles O; Semba RD; Ferrucci L; Satterfield S; Nevitt M; Cauley JA; Harris T;
J Am Geriatr Soc; 2016 Dec; 64(12):e304-e308. PubMed ID: 27910102
[TBL] [Abstract][Full Text] [Related]
14. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
[TBL] [Abstract][Full Text] [Related]
15. PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.
Ginsberg C; Craven TE; Chonchol MB; Cheung AK; Sarnak MJ; Ambrosius WT; Killeen AA; Raphael KL; Bhatt UY; Chen J; Chertow GM; Freedman BI; Oparil S; Papademetriou V; Wall BM; Wright CB; Ix JH; Shlipak MG;
Clin J Am Soc Nephrol; 2018 Dec; 13(12):1816-1824. PubMed ID: 30425104
[TBL] [Abstract][Full Text] [Related]
16. Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men.
Mirza MA; Karlsson MK; Mellström D; Orwoll E; Ohlsson C; Ljunggren O; Larsson TE
J Bone Miner Res; 2011 Apr; 26(4):857-64. PubMed ID: 20928885
[TBL] [Abstract][Full Text] [Related]
17. Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.
Lane NE; Parimi N; Corr M; Yao W; Cauley JA; Nielson CM; Ix JH; Kado D; Orwoll E;
J Bone Miner Res; 2013 Nov; 28(11):2325-32. PubMed ID: 23677793
[TBL] [Abstract][Full Text] [Related]
18. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
[TBL] [Abstract][Full Text] [Related]
19. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
[TBL] [Abstract][Full Text] [Related]
20. FGF23-Klotho Axis and Fractures in Patients Without and With Early CKD: A Case-Cohort Analysis of CARTaGENE.
Desbiens LC; Sidibé A; Ung RV; Mac-Way F
J Clin Endocrinol Metab; 2022 May; 107(6):e2502-e2512. PubMed ID: 35139204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
